These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 29121432
1. Effectiveness of alpine climate treatment for children with difficult to treat atopic dermatitis: Results of a pragmatic randomized controlled trial (DAVOS trial). Fieten KB, Schappin R, Zijlstra WT, Figee L, Beutler J, Raymakers F, van Os-Medendorp H, Stellato R, Vandewall M, Winkelhof J, Uniken Venema M, Bruijnzeel-Koomen CAFM, Rijssenbeek-Nouwens L, van der Ent CK, van Hoffen E, Meijer Y, Pasmans SGMA. Clin Exp Allergy; 2018 Feb; 48(2):186-195. PubMed ID: 29121432 [Abstract] [Full Text] [Related]
2. Comparing high altitude treatment with current best care in Dutch children with moderate to severe atopic dermatitis (and asthma): study protocol for a pragmatic randomized controlled trial (DAVOS trial). Fieten KB, Zijlstra WT, van Os-Medendorp H, Meijer Y, Venema MU, Rijssenbeek-Nouwens L, l'Hoir MP, Bruijnzeel-Koomen CA, Pasmans SG. Trials; 2014 Mar 26; 15():94. PubMed ID: 24670079 [Abstract] [Full Text] [Related]
5. Effectiveness of a nurse-led one-to-one education programme in addition to standard care in children with atopic dermatitis: a multicentre randomized control trial. Barbarot S, Aubert H, Vibet MA, Leray M, Foureau A, Elan F, Menneron L, Stalder JF, Mazereeuw-Hautier J, Phan A, Droitcourt C, Bursztejn AC, Boralevi F, Chiaverini C, Raison-Peyron N, Lasek A, Misery L, Abasq C, Mallet S. Br J Dermatol; 2024 Jul 16; 191(2):177-186. PubMed ID: 38863109 [Abstract] [Full Text] [Related]
6. Alpine climate treatment of atopic dermatitis: a systematic review. Fieten KB, Weststrate AC, van Zuuren EJ, Bruijnzeel-Koomen CA, Pasmans SG. Allergy; 2015 Jan 16; 70(1):12-25. PubMed ID: 25130620 [Abstract] [Full Text] [Related]
7. The influence of treatment in alpine and moderate maritime climate on the composition of the skin microbiome in patients with difficult to treat atopic dermatitis. van Mierlo MMF, Totté JEE, Fieten KB, van den Broek TJ, Schuren FHJ, Pardo LM, Pasmans SGMA. Clin Exp Allergy; 2019 Nov 16; 49(11):1437-1445. PubMed ID: 31509295 [Abstract] [Full Text] [Related]
12. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Wahn U, Bos JD, Goodfield M, Caputo R, Papp K, Manjra A, Dobozy A, Paul C, Molloy S, Hultsch T, Graeber M, Cherill R, de Prost Y, Flare Reduction in Eczema with Elidel (Children) Multicenter Investigator Study Group. Pediatrics; 2002 Jul 16; 110(1 Pt 1):e2. PubMed ID: 12093983 [Abstract] [Full Text] [Related]
13. Randomized controlled trial of a single dermatology nurse consultation in primary care on the quality of life of children with atopic eczema. Chinn DJ, Poyner T, Sibley G. Br J Dermatol; 2002 Mar 16; 146(3):432-9. PubMed ID: 11952543 [Abstract] [Full Text] [Related]
15. Efficacy trial of bioresonance in children with atopic dermatitis. Schöni MH, Nikolaizik WH, Schöni-Affolter F. Int Arch Allergy Immunol; 1997 Mar 16; 112(3):238-46. PubMed ID: 9066509 [Abstract] [Full Text] [Related]
16. Inhaled corticosteroids in children with persistent asthma: effects on growth. Zhang L, Prietsch SO, Ducharme FM. Evid Based Child Health; 2014 Dec 16; 9(4):829-930. PubMed ID: 25504972 [Abstract] [Full Text] [Related]
17. Effect of Oral Administration of a Mixture of Probiotic Strains on SCORAD Index and Use of Topical Steroids in Young Patients With Moderate Atopic Dermatitis: A Randomized Clinical Trial. Navarro-López V, Ramírez-Boscá A, Ramón-Vidal D, Ruzafa-Costas B, Genovés-Martínez S, Chenoll-Cuadros E, Carrión-Gutiérrez M, Horga de la Parte J, Prieto-Merino D, Codoñer-Cortés FM. JAMA Dermatol; 2018 Jan 01; 154(1):37-43. PubMed ID: 29117309 [Abstract] [Full Text] [Related]
20. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. Blauvelt A, de Bruin-Weller M, Gooderham M, Cather JC, Weisman J, Pariser D, Simpson EL, Papp KA, Hong HC, Rubel D, Foley P, Prens E, Griffiths CEM, Etoh T, Pinto PH, Pujol RM, Szepietowski JC, Ettler K, Kemény L, Zhu X, Akinlade B, Hultsch T, Mastey V, Gadkari A, Eckert L, Amin N, Graham NMH, Pirozzi G, Stahl N, Yancopoulos GD, Shumel B. Lancet; 2017 Jun 10; 389(10086):2287-2303. PubMed ID: 28478972 [Abstract] [Full Text] [Related] Page: [Next] [New Search]